Enbrel etanercept: Phase III data; marketed to treat rheumatoid arthritis (RA) and psoriatic arthritis

In a double-blind, U.S. Phase III trial in 583 patients, 49% of patients given 50

Read the full 156 word article

How to gain access

Continue reading with a
two-week free trial.